Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...
We are so back. All Star Tower Defense is back with a new paint job, new animation, characters, and even All Star Tower Defense X codes to boot. You will finally be able to have all your bragging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback